GlucoTrack Executes Debt-for-Equity Exchange to Reduce Obligations

The latest announcement is out from GlucoTrack ( (GCTK) ).

On April 13, 2026, Glucotrack, Inc. signed an Exchange Agreement with an existing investor to carve out a new $600,000 promissory note from a prior $3.6 million note and then swap that new “Partitioned Note” for 895,000 common shares. The move reduces the balance of the original note while converting a portion of debt into equity, with issuance constrained by a 19.9% ownership cap that may require tranche-based share delivery and leaves any unexchanged note balance outstanding under existing terms.

The transaction, executed as a private placement under U.S. securities law exemptions, signals continued balance-sheet management by Glucotrack as it restructures obligations without cash outlay or commission costs. For stakeholders, the exchange eases near-term debt pressure but introduces potential dilution for existing shareholders as additional tranches of stock may be issued over time within the agreed beneficial ownership limit.

Spark’s Take on GCTK Stock

According to Spark, TipRanks’ AI Analyst, GCTK is a Neutral.

The score is primarily held down by weak financial performance (pre-revenue, large ongoing losses, and sustained cash burn) and bearish technicals (below major moving averages with negative MACD). Corporate events provide some offset via encouraging clinical/ regulatory progress and stronger IP, but valuation remains constrained by lack of earnings and no dividend.

To see Spark’s full report on GCTK stock, click here.

More about GlucoTrack

Glucotrack, Inc. operates in the medical technology and healthcare sector, focusing on products and solutions related to glucose monitoring and diabetes management. The company raises capital through debt and equity instruments and actively manages its financing structure with institutional investors to support its operational and growth needs.

Average Trading Volume: 1,425,740

Technical Sentiment Signal: Strong Sell

Current Market Cap: $1.29M

See more data about GCTK stock on TipRanks’ Stock Analysis page.